- Home
- ZNTL vs REFI Comparison
ZNTL vs REFI Comparison
Compare ZNTL & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZNTL | REFI |
|---|---|---|
| Founded | 2014 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 313.9M | 253.6M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ZNTL | REFI |
|---|---|---|
| Price | $4.03 | $11.27 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $6.60 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 144.5K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 15.79% |
| EPS Growth | ★ 18.03 | N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $48,857,628.00 |
| Revenue This Year | N/A | $17.47 |
| Revenue Next Year | N/A | $0.06 |
| P/E Ratio | ★ N/A | $49.22 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.13 | $10.74 |
| 52 Week High | $6.95 | $14.97 |
Technical Indicators
Market Signals| Indicator | ZNTL | REFI |
|---|---|---|
| Relative Strength Index (RSI) | 50.58 | 38.31 |
| Support Level | $3.75 | $10.74 |
| Resistance Level | $4.34 | $12.45 |
| Average True Range (ATR) | 0.30 | 0.28 |
| MACD | -0.06 | -0.09 |
| Stochastic Oscillator | 26.72 | 11.33 |
Price Performance
Historical ComparisonAbout ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. The Company operates as one operating segment, and its primary investment objective is to provide attractive, risk-adjusted returns for stockholders over time, mainly through consistent current income (dividends and distributions) and secondarily, through capital appreciation. The company operates mainly within the USA itself.